Unilever shares edged slightly higher in Thursday trading after the company confirmed a fresh move deeper into the U.S. wellness market through the acquisition of greens supplement brand Grüns. The deal signals another step in the consumer goods giant’s ongoing transformation away from traditional packaged food exposure and toward higher-growth beauty, wellbeing, and nutrition categories.
The company did not disclose the purchase price, but indicated the transaction is expected to close later in the year pending regulatory approvals and customary closing conditions. The announcement comes just days after Unilever’s food arm advanced its strategic alignment with McCormick, highlighting a rapid sequence of portfolio restructuring moves.
Investors reacted cautiously but positively, with shares ticking up modestly as the market digested the expansion of Unilever’s supplements footprint.
Unilever’s acquisition of Grüns adds another fast-growing brand to its expanding portfolio of health-focused products. The U.S.-based company, founded in 2023 by Chad Janis, operates in the vitamins, minerals, and supplements (VMS) space with a focus on daily greens nutrition delivered through gummies and blended supplement formats.
Unilever PLC, UL
Grüns has positioned itself in the increasingly competitive wellness segment, offering fruit, vegetable, and vitamin-based formulations aimed at mainstream consumers seeking convenient nutrition solutions. The brand has also gained traction through a hybrid distribution model combining direct-to-consumer sales with retail partnerships across the United States.
The company reportedly achieved a valuation near $500 million following a Series B round in 2025, underscoring investor appetite for supplement brands targeting everyday wellness consumption.
The acquisition aligns closely with Unilever’s broader strategic pivot toward higher-margin, higher-growth categories such as beauty and wellbeing. The group has been steadily reshaping its portfolio, placing less emphasis on legacy food brands while scaling up its presence in health-oriented consumer products.
Unilever already owns a growing stable of supplement and wellness brands, including Nutrafol, SmartyPants Vitamins, Olly Nutrition, and Liquid I.V. The addition of Grüns further strengthens this ecosystem, giving the company deeper exposure to the fast-expanding U.S. supplements market.
Leadership at Unilever described the acquisition as a significant opportunity to broaden reach in wellness categories that continue to outperform traditional packaged goods.
The Grüns deal follows closely on the heels of Unilever’s broader restructuring efforts in its food division, including a major merger with McCormick that reshaped its legacy packaged food exposure. That transaction, valued in the tens of billions, is part of a wider plan to streamline operations and unlock value from non-core segments.
Chief Executive Fernando Fernandez has previously framed these moves as necessary to reposition Unilever toward categories with stronger long-term growth potential. The company’s beauty and wellbeing division alone generated €12.8 billion in turnover in 2025, accounting for roughly a quarter of total group revenue and posting double-digit growth in the segment.
Analysts note that if Unilever completes its planned restructuring, the company could increasingly be compared with consumer staples peers focused on personal care and premium wellness rather than traditional food manufacturing.
The post Unilever (UL) Stock; Edges Higher as It Expands Into Supplements With Grüns Deal appeared first on CoinCentral.


